Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03NZV
|
||||
Former ID |
DIB000727
|
||||
Drug Name |
SC-236
|
||||
Synonyms |
SC-791; SC-872; COX-2 inhibitors (anticancer), Pfizer; COX-2 inhibitors (anticancer), Pharmacia
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Terminated | [547069] | ||
Company |
GD Searle & Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H11ClF3N3O2S
|
||||
Canonical SMILES |
n1n(c(cc1C(F)(F)F)c1ccc(cc1)Cl)c1ccc(S(=O)(=O)N)cc1
|
||||
CAS Number |
CAS 170569-86-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [527033] | |
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
NF-kappa B signaling pathway | |||||
VEGF signaling pathway | |||||
TNF signaling pathway | |||||
Retrograde endocannabinoid signaling | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Oxytocin signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Leishmaniasis | |||||
Pathways in cancer | |||||
Chemical carcinogenesis | |||||
MicroRNAs in cancer | |||||
Small cell lung cancer | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.